BUFFALO, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Cleveland BioLabs, Inc. (CBLI), the years in the column headers in the Consolidated Balance Sheets table were incorrect. With the exception of the headers, all other financials were correct. The corrected table follows:
| CLEVELAND BIOLABS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED BALANCE SEEETS | ||
| March 31, | December 31, | |
| 2013 | 2012 | |
| (unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 19,769,013 | $ 25,652,083 |
| Short-term investments | 1,286,861 | 2,633,944 |
| Accounts receivable | 477,180 | 41,896 |
| Other current assets | 1,136,042 | 1,078,040 |
| Total current assets | 22,669,096 | 29,405,963 |
| Equipment, net | 910,897 | 986,553 |
| Restricted cash | 1,541,842 | 1,577,920 |
| Other long-term assets | 61,592 | 39,597 |
| Total assets | $ 25,183,427 | $ 32,010,033 |
| LIABILITIES & STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $ 1,234,575 | $ 1,523,875 |
| Accrued expenses | 3,285,022 | 2,410,592 |
| Deferred revenue | 3,024,565 | 3,314,918 |
| Accrued warrant liability | 7,553,382 | 4,105,659 |
| Current portion of capital lease obligation | 74,276 | 71,679 |
| Total current liabilities | 15,171,820 | 11,426,723 |
| Noncurrent portion of capital lease obligation | 78,030 | 97,602 |
| Commitments and contingencies | -- | -- |
| Total liabilities | 15,249,850 | 11,524,325 |
| Stockholders' equity: | ||
| Total Cleveland BioLabs, Inc. stockholders' equity (deficit) | (3,130,884) | 6,333,167 |
| Noncontrolling interest in stockholders' equity | 13,064,461 | 14,152,541 |
| Total stockholders' equity | 9,933,577 | 20,485,708 |
| Total liabilities and stockholders' equity | $ 25,183,427 | $ 32,010,033 |
Contact:
Rachel Levine, Vice President, Investor Relations
Cleveland BioLabs, Inc.
T: (646) 284-9439
E: rlevine@cbiolabs.com
Contact:
